With rigorous economic research and practical policy solutions, we focus on the issues and institutions that are critical to global development. Explore our core themes and topics to learn more about our work.
In timely and incisive analysis, our experts parse the latest development news and devise practical solutions to new and emerging challenges. Our events convene the top thinkers and doers in global development.
As more countries rise out of poverty, CGD’s work in this area focuses on the inequities and emerging problems that jeopardize global health progress.
As more countries rise out of poverty, CGD is focusing on the inequities and emerging problems that jeopardize global health progress: How should governments allocate scarce health budgets rationally and equitably? How can the world advance global health security and fight infectious diseases? What can be done to address treatment inequalities between developed and developing countries? What are the benefits of, mechanisms for, and threats to, greater family planning provision? CGD research helps policymakers build sustainable health systems, respond to shifting realities, and deliver value for money.
The Global Fund’s Office of the Inspector General (OIG) released a new audit report on Wambo.org, its online procurement platform for drugs and other health commodities. The headline: despite high marks from its users, Wambo.org is not yet on track to deliver the projected savings. But more than the headline, a close read of the report narrative helps us understand why reality does not yet reflect the Global Fund’s optimistic assumptions—and, reading between the lines, suggests three important lessons for the Global Fund and other international funders
With aid budgets shrinking and even low-income countries increasingly faced with cofinancing requirements, this is the right time for global health funders such as the Global Fund and their donors to formally introduce Health Technology Assessment (HTA), both at the central operations level and at the national or regional level in recipient countries. In this CGD Note, we explain why introducing HTA is a good idea. Specifically, we outline six benefits that the application of HTA could bring to the Global Fund, the countries it supports, and the broader global health community.
We analyzed a large-scale municipal water disinfection program in Mexico in 1991 that rapidly increased access to chlorinated water. Our results suggest that childhood diarrheal disease mortality in Mexico would have declined by 86 percent if all municipalities had good quality infrastructure—a decline consistent with historical experience.
In April this year, the National Academies of Science, Engineering, and Medicine (NASEM) published a report making the case for “Integrating Clinical Research into Epidemic Response.” As reflected in its title, the 250-page-plus-appendices report makes a strong evidence-informed argument for integrating health service delivery with clinical research conducted during epidemics. The goal is to produce critical information on the efficacy and safety of potential therapeutics and vaccines for tackling such epidemics after they occur, or, better still, for preventing them from happening. Earlier this week, the group reconvened at the Wellcome Trust to discuss “what next.” The need to focus on systematic support and funding for the data collection and research functions in outbreak-affected countries came out again as the top priority.
The Center for Global Development—with Results for Development—is pleased to host this year's Philip A. Musgrove Memorial Lecture, to be delivered by Ricardo Bitran. Philip A. Musgrove worked on a broad set of topics in health economics and policy in developing countries. In each, he made major contributions thanks to his keenly analytical mind and implacable logic, along with his dry sense of humor. Setting priorities in health was among Philip’s preferred subjects. While at the World Bank he worked on the World Development Report 1993: Investing in Health. A main and controversial prescription from the Report was that low- and middle-income countries could tackle a substantive part of their burden of disease by delivering a health benefits package of prioritized, cost-effective interventions.
OPIC recently announced it will invest $2 million in a Development Impact Bond (DIB) aimed at improving the availability and quality of cataract surgery services in Cameroon. Specifically, OPIC’s investment will support the Magrabi ICO-Cameroon Eye Institute, a new hospital with an efficiency and financing model based on the acclaimed Aravind Eye Hospitals, over several years. The OPIC news is particularly exciting for four reasons.
In many countries, it is difficult to raise taxes and therefore difficult to increase spending on health care. Nevertheless, many of the factors that determine population health—and how it is distributed among citizens—do not involve spending more on healthcare services, per se. Rather, the burden of many non-communicable diseases and external injuries can be influenced by creative reform of taxes and subsidies. Taxing tobacco, alcohol, and sugar-sweetened beverages can reduce consumption of products which contribute to cardiovascular disease, traffic accidents, and diabetes. Subsidies for condoms, vaccines, and TB diagnostics can reduce the prevalence of many important infectious diseases. Ramanan Laxminarayan, Director of the Center for Disease Dynamics, Economics & Policy, will present findings from his research with Ian Parry at the International Monetary Fund on the potential for health gains from taxes and subsidies. This lunchtime talk will be moderated by William Savedoff, Senior Fellow at the Center for Global Development.